It suggested that AR-overexpression could block out the effect of MTNR1A, and AR acted as an important downstream factor of MTNR1A in aromatase production, thus playing a vital role in the PCOS-related pathophysiological process of androgen excess. The gene discussed is CYP19A1; the disease is hyperandrogenism.